LucyRx Revenue and Competitors
Employee Data
- LucyRx has 90 Employees.
- LucyRx grew their employee count by 329% last year.
LucyRx's People
Name | Title | Email/Phone |
---|
LucyRx Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | N/A | 18 | 29% | N/A | N/A |
#2 | N/A | 2 | 100% | N/A | N/A |
#3 | N/A | 177 | 17% | N/A | N/A |
#4 | N/A | 69 | -12% | N/A | N/A |
#5 | N/A | 102 | 55% | N/A | N/A |
#6 | N/A | 147 | 40% | N/A | N/A |
#7 | N/A | 5 | 0% | N/A | N/A |
#8 | N/A | 243 | 25% | N/A | N/A |
#9 | N/A | 159 | 39% | N/A | N/A |
#10 | N/A | 4241 | 6% | N/A | N/A |
What Is LucyRx?
LucyRx is an independent, next-generation pharmacy benefits manager transforming the industry with data clarity, fiduciary alignment, and a commitment to putting people first. Built on decades of leadership experience, LucyRx was founded to challenge outdated norms and create meaningful change. At the heart of LucyRx’s mission is LucyIQ, an advanced AI-powered analytics platform delivering actionable insights that empower plan sponsors to manage benefits, lower costs and improve care.\n\nOur solutions make prescription management more accessible, understandable, and personal, addressing gaps in the PBM market with a high-touch service model and advanced technology. Launched in 2023 with a $500 million capital investment, LucyRx partners with over 65,000 pharmacies nationwide and serves over 1,200 clients. By eliminating hidden fees and reimagining pharmacy benefits, LucyRx is improving outcomes, enhancing experiences, and empowering stakeholders—clients, members, and employees alike. For more information, visit www.lucyrx.com.
keywords:N/AN/A
Total Funding
90
Number of Employees
N/A
Revenue (est)
329%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $24.9M | 90 | -3% | N/A |
#2 | $15M | 90 | -8% | N/A |
#3 | $14.2M | 91 | -3% | N/A |
#4 | $35M | 91 | 5% | N/A |
#5 | $20.9M | 92 | 19% | N/A |